BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 37055914)

  • 1. The CD4+ T cell repertoire specific for citrullinated peptides shows evidence of immune tolerance.
    McElwee MK; Dileepan T; Mahmud SA; Jenkins MK
    J Exp Med; 2023 Dec; 220(12):. PubMed ID: 37831103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Citrullination Modification in CD4
    Chen Y; Teng Y; Xu P; Wang S
    Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis.
    Feitsma AL; van der Voort EI; Franken KL; el Bannoudi H; Elferink BG; Drijfhout JW; Huizinga TW; de Vries RR; Toes RE; Ioan-Facsinay A
    Arthritis Rheum; 2010 Jan; 62(1):117-25. PubMed ID: 20039411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell repertoire to citrullinated self-peptides in healthy humans is not confined to the HLA-DR SE alleles; Targeting of citrullinated self-peptides presented by HLA-DP4 for tumour therapy.
    Brentville VA; Symonds P; Cook KW; Daniels I; Pitt T; Gijon M; Vaghela P; Xue W; Shah S; Metheringham RL; Durrant LG
    Oncoimmunology; 2019; 8(5):e1576490. PubMed ID: 31069134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy.
    Choudhury RH; Symonds P; Paston SJ; Daniels I; Cook KW; Gijon M; Metheringham RL; Brentville VA; Durrant LG
    J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35140112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
    Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of posttranslational modifications in generating neo-epitopes that bind to rheumatoid arthritis-associated HLA-DR alleles and promote autoimmune T cell responses.
    Becart S; Whittington KB; Prislovsky A; Rao NL; Rosloniec EF
    PLoS One; 2021; 16(1):e0245541. PubMed ID: 33465118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-translational modifications such as citrullination are excellent targets for cancer therapy.
    Brentville VA; Vankemmelbeke M; Metheringham RL; Durrant LG
    Semin Immunol; 2020 Feb; 47():101393. PubMed ID: 31932199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How RA Associated HLA-DR Molecules Contribute to the Development of Antibodies to Citrullinated Proteins: The Hapten Carrier Model.
    Roudier J; Balandraud N; Auger I
    Front Immunol; 2022; 13():930112. PubMed ID: 35774784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human MHC-II with Shared Epitope Motifs Are Optimal Epstein-Barr Virus Glycoprotein 42 Ligands-Relation to Rheumatoid Arthritis.
    Trier N; Izarzugaza J; Chailyan A; Marcatili P; Houen G
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses to citrullinated and homocitrullinated peptides in healthy donors are not restricted to the HLA SE shared allele and can be selected into the memory pool.
    Choudhury RH; Daniels I; Vaghela P; Atabani S; Kirk T; Symonds P; Cook KW; Al-Omari A; Weston D; Shah S; Hutchinson D; Paston SJ; Metheringham RL; Brentville VA; Durrant LG
    Immunology; 2023 Aug; 169(4):467-486. PubMed ID: 37055914
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.